SASSARI, Italy & PRINCETON, N.J.--(BUSINESS WIRE)--ViroStatics, srl, a privately-held pharmaceutical company focused on the discovery and development of combination therapeutics in HIV/AIDS, virology, and other chronic diseases, today announced the formation of a Scientific Advisory Board (SAB). Chaired by Daniel Kuritzkes, MD, Director of AIDS Research, Brigham & Women's Hospital in Boston, the Board will provide the Company with valuable assistance in determining and managing the scientific mission as well as the prioritization and operation of its scientific and clinical activities.
